Changes

Jump to: navigation, search

Artificial Retina

206 bytes added, 14:00, 6 February 2018
/* M&A Activity in the Space */
|}
<br>
[[Image:Artifical_Retina_PCS_01.png|center|1000px1100px]]
[[Image:KTP_Laser_04.png|center|50px]]
=Top Assignees=
[[Image:Artifical_Retina_PCS_03.png|center|1000px]]
[[Image:Top Assignees_Artificial_Retina_PCS.png|center|1000px]]
===(A) Second Sight Medical Products Inc.===
*They have patents that focus on improving the user comfort and user feedback.
[[Image:Artifical_Retina_PCS_04.png|center|900px1000px]]
<br>
=== (B) Pixium Vision SA===
*The patents mostly discuss about the constructional features like, designing photodiodes, mounting and sealing features of a retinal implant.
[[Image:Artifical_Retina_PCS_05_1.png|center|900px1000px]][[Image:Artifical_Retina_PCS_05_2.png|center|900px1000px]]
<br>
==IP Activity==
[[Image:Artifical_Retina_PCS_07.png|center|1000px900px]]<br> 
*IP activity started 20 years and saw a peak in the number of publications in 2008, followed by 2012 and 2015.
*The number of applications shot to the peak value during the period of 2006-2007. <br>
==Geographical Distribution==
[[Image:Artifical_Retina_PCS_08.png|center|700px900px]]<br>
*Most of the patents in this technology are from US or Europe.
*Japan and China top the Asian subcontinent, in the number of patent filings.
=Technical Insights: CPC Distribution in Top Assignees=
[[Image:Artifical_Retina_PCS_09.png|center|1000px950px]]<br>
*All the product based companies- Second Sight Medical Products, Pixium Vision, Optobionics Corporation and Retina Implant AG have heavy presence on the therapy based classes- A61N, A61F, A61B.
*Second Sight Medical Products has the most number of filings for the printed circuit bases class- H05K.
==Technology Concepts:==
[[Image:Artifical_Retina_PCS_10.png|center|1000px950px]]<br>
*Second Sight Medical Products, Pixium Vision and Doheny Eye Institute patents disclose technologies related to Neuro-prosthetics, Blindness, Artificial Organs and Prosthetics.
*Second Sight Medical Products, Pixium Vision has more patents on Electrotherapy.
<br>
=Value Chain Analysis=<br>
=M&A Activity in the Space=
*Okuvision and Retina Implant merge together under the parent company Retina Implant AG. [[https://www.retina-implant.de/en/news/02022017-02022017-we-have-moved/ Retina Implant AG], February 2017]
*NIDEK -- Two Sister Companies Merge to Combine Efforts in U.S. Ophthalmic Industry. [[https://globenewswire.com/news-release/2005/10/13/334767/87801/en/NIDEK-Two-Sister-Companies-Merge-to-Combine-Efforts-in-U-S-Ophthalmic-Industry.html Globenewswire], October 2005]
<br>
 
=Powerpoint Presentation=
[[media:PCS_Artificial Retina.pptx|PCS_Artificial Retina]]
349
edits